The role of ANRIL in regulation of DNA damage response makes it likely for it to have a critical role in breast cancer pathogenesis given that BRCA1, the most well-known breast cancer susceptibility gene mainly participates in DNA damage-induced cell cycle checkpoint activation and DNA repair (19). Here, CDKN2B-AS1 is linked to breast carcinoma.